ADMA Biologics's total assets for Q1 2026 were $665.18M, an increase of 6.56% from the previous quarter. ADMA total liabilities were $274.86M for the fiscal quarter, a 87.08% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.